Transform 50+ years of handwritten pharmaceutical R&D data with 93.2% accuracy. Our patent-pending OCSR™ technology creates the world's first auto-compound repository ELN integration.
Witness the power of our patent-pending AI transforming pharmaceutical R&D
Unlock decades of dormant R&D value. We're the only platform successfully digitizing handwritten lab notebooks with 93.2% accuracy.
Extract molecular structures from any source: printed PDFs, hand-drawn sketches, photos, or ancient journal scans.
Printed Accuracy
Hand-drawn Accuracy
Transform your R&D with the only platform that truly understands pharmaceutical data
World's first AI achieving 93.2% accuracy on handwritten pharmaceutical documents. Our OCSR engine digitizes decades of handwritten lab notebooks, creating searchable, actionable intelligence from previously inaccessible data. No competitor globally has this capability.
93.2% Accuracy - World's FirstIdentify chemical structures throughout ingested documents - whether printed or hand-drawn. Our patent-pending technology creates auto-compound repositories, transforming static documents into dynamic, searchable molecular databases.
Patent-Pending TechnologyBeyond simple structure recognition - understand relationships, predict properties, and discover patterns across your entire compound library. AI-powered insights that accelerate discovery.
AI-Powered DiscoveryComprehensive patent landscape analysis with chemical structure awareness. Identify prior art, freedom-to-operate, and competitive intelligence with unprecedented accuracy.
Strategic IntelligenceAdvanced molecular editing capabilities with batch processing support. Design, modify, and analyze thousands of compounds simultaneously while maintaining complete data privacy.
Batch Processing EnabledSeamlessly integrate with your existing ELN using our private compound repositories. Natural language queries across all your experimental data with OCSR-enhanced understanding.
Seamless IntegrationBreak language barriers in global R&D. Support for 40+ languages including Japanese, Chinese, German, and more. Automatically translate and analyze documents while preserving chemical structure integrity.
40+ Languages SupportedYour own secure knowledge cloud. No more reliance on SharePoint, Google Drive, or other third-party clouds. Complete data sovereignty with enterprise-grade security and AI-powered search.
Zero External DependenciesFrom molecule to market, every insight at your fingertips
Transform molecular data into actionable insights for drug discovery and optimization.
Navigate IP landscapes with structure-based patent searching across global databases.
Power your pipeline with AI-driven insights from your complete knowledge base.
Transform your entire pharmaceutical knowledge base into an intelligent, queryable system
Powerful RAG capabilities that extend beyond documents to your entire software ecosystem. Query across ELNs, compound repositories, and experimental data with natural language.
Private biomedical RAG engine with deep understanding of pharmacokinetics, pharmacodynamics, ADMET properties, and structure-activity relationships. Ask complex questions, get expert answers.
Not just search - true reasoning across your private data. Connect insights from disparate sources, identify patterns, and generate hypotheses based on your entire knowledge base.
Your private compound repositories become intelligent knowledge bases. Query structure-activity relationships, predict properties, and explore chemical space with unprecedented depth.
Molecular Intelligence:
"What compounds in our library have shown activity against EGFR with IC50 < 100nM and good oral bioavailability?"
Structure Modification:
"Thalidomide caused birth defects but now treats cancer. Modify it to keep the cancer benefits while making it completely safe for pregnant women"
Retrosynthesis Analysis:
"Suggest three different retrosynthetic pathways for synthesizing Paxlovid using readily available starting materials"
Patent Intelligence:
"Find all Japanese patents filed in the last 5 years related to SGLT2 inhibitors and analyze their structural novelty"
Cross-Domain Analysis:
"Compare the binding affinity predictions from our 2019 handwritten lab notebooks with the actual IC50 values from 2023 clinical trials for our lead compounds"
Your data. Your privacy. Unlimited intelligence.
Built from the ground up for pharmaceutical R&D excellence
Proprietary optical chemical structure recognition that understands both printed and handwritten structures with unmatched accuracy.
State-of-the-art protein folding predictions with integrated analysis for protein-protein and protein-ligand interactions.
Seamlessly process documents, images, spectra, and molecular data through our unified intelligence pipeline.
Comprehensive molecular property predictions, ADMET profiling, and structure-activity relationship modeling.
Structure Visualization
Protein-Ligand Pairs
Binding Analysis
Your intellectual property is your competitive advantage. We protect it like our own.
Your data never leaves your control. All processing happens within your secure environment.
256-bit AES encryption at rest and in transit. Military-grade security for your most sensitive data.
Granular permissions ensuring teams only access what they need. Complete audit trails for compliance.
Deploy within your infrastructure. No cloud dependency. Complete data sovereignty.
The difference between searching and discovering
Months searching through paper notebooks
Instant search across 50+ years of data
Manual transcription errors and lost data
93.2% accurate automated digitization
Siloed compound information
Unified, searchable compound intelligence
Limited structure-activity insights
AI-powered SAR and property predictions
Compliance nightmares with paper trails
Complete audit trails and 21 CFR Part 11 compliance
Faster Discovery
Time Saved
Possibilities
Join leading pharmaceutical companies already accelerating discovery with OCSR™.ai
No credit card required • Deploy on-premises • Full support